Combined use of the BinaxNOW Staphylococcus aureus test with the Clearview PBP2a assay for the early detection of methicillin-resistant S. aureus from positive blood cultures

被引：10

作者：

Kong, Haishen ^{[1
]}

Tong, Ling ^{[2
]}

Zhang, Weili ^{[1
]}

Fu, Yajie ^{[2
]}

Li, Xuefen ^{[1
,2
]}

机构：

[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China

[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2014年 / 78卷 / 03期

关键词：

Methicillin-resistant Staphylococcus aureus; Bacteremia; Identification; Immunochromatographic assay; Blood culture; RAPID IDENTIFICATION; BACTEREMIA; LENGTH; HOSPITALIZATION; PATIENT; COST; MECC;

D O I：

10.1016/j.diagmicrobio.2013.11.018

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The use of combination 2 novel immunochromatographic assays for same-day detection of methicillinresistant Staphylococcus aureus (MRSA) from positive blood cultures was evaluated. Compared to the standard culture methods, the BinaxNOW (R) S.aureus test demonstrated 98.7% sensitivity and 100% specificity in correctly identifying S. aureus. The sensitivity and specificity of the Clearview (R) PBP2a assay in differentiating MRSA from methicillin-susceptible S. aureus were 97.1% and 100%. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：226 / 228

页数：3

共 17 条

[11] Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies [J].